Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study

This longitudinal, multisite study reports a high prevalence of norovirus infection and norovirus-positive diarrhea and describes patterns of age acquisition, disease severity, genogroup-specific immunity, and relationships between norovirus and undernutrition in the first 2 years of life.

[1]  Mark A. Miller,et al.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.

[2]  K. Shioda,et al.  Global age distribution of pediatric norovirus cases. , 2015, Vaccine.

[3]  Jamie Perin,et al.  Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis , 2015, The Lancet.

[4]  J. Vinjé,et al.  Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status , 2014, The Journal of infectious diseases.

[5]  G. Kang,et al.  Microbiologic methods utilized in the MAL-ED cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Robert E Black,et al.  The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  L. Caulfield,et al.  An instrument for the assessment of diarrhoeal severity based on a longitudinal community-based study , 2014, BMJ Open.

[8]  M. Gambhir,et al.  Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. , 2014, American journal of epidemiology.

[9]  G. Kang,et al.  In praise of birth cohorts: norovirus infection, disease, and immunity. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Black,et al.  Multiple Norovirus Infections in a Birth Cohort in a Peruvian Periurban Community , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Farrar,et al.  Endemic Norovirus Infections in Children, Ho Chi Minh City, Vietnam, 2009–2010 , 2013, Emerging infectious diseases.

[12]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[13]  D. Goldberg,et al.  Infections with Spore-forming Bacteria in Persons Who Inject Drugs, 2000–2009 , 2013, Emerging infectious diseases.

[14]  T. Farag,et al.  Statistical Methods in the Global Enteric Multicenter Study (GEMS) , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Dani Cohen,et al.  The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Graham,et al.  Norovirus vaccine against experimental human Norwalk Virus illness. , 2011, The New England journal of medicine.

[17]  C. Mathers,et al.  Global, regional, and national causes of child mortality in 2008: a systematic analysis , 2010, The Lancet.

[18]  M. O'Ryan,et al.  Symptomatic and Asymptomatic Rotavirus and Norovirus Infections During Infancy in a Chilean Birth Cohort , 2009, The Pediatric infectious disease journal.

[19]  Manish M Patel,et al.  Systematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis , 2008, Emerging infectious diseases.

[20]  Mercedes Onis,et al.  WHO Child Growth Standards based on length/height, weight and age , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[21]  K. Hedlund,et al.  A Homozygous Nonsense Mutation (428G→A) in the Human Secretor (FUT2) Gene Provides Resistance to Symptomatic Norovirus (GGII) Infections , 2005, Journal of Virology.

[22]  J. Sarangi,et al.  Clinical manifestation of norovirus gastroenteritis in health care settings. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Xi Jiang,et al.  Human susceptibility and resistance to Norwalk virus infection , 2003, Nature Medicine.

[24]  D P Byar,et al.  Estimating the population attributable risk for multiple risk factors using case-control data. , 1985, American journal of epidemiology.

[25]  M. Estes,et al.  Norovirus gastroenteritis. , 2009, The New England journal of medicine.